Director/PDMR Shareholding

RNS Number : 0810W

Circassia Pharmaceuticals Plc

06 December 2019

 

Director/PDMR Shareholding

Oxford, UK - 6 December 2019: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 5 December 2019, Garry Watts, who will be appointed as Senior Independent Director to the Board of Circassia on 2 March 2020, purchased 477,340 Ordinary Shares on the London Stock Exchange at a price of 21.0 pence per share.

Contacts

Circassia Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications	Tel: [phone]
Peel Hunt (Nominated Adviser and Joint Broker) James Steel / Dr Christopher Golden	Tel: [phone]
finnCap (Joint Broker) Geoff Nash / Alice Lane	Tel: [phone]
Numis Securities (Joint Broker) James Black / Freddie Barnfield	Tel: [phone]
FTI Consulting Simon Conway / Ciara Martin	Tel: [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Garry Watts
2.	Reason for the notification
a.	Position/status	Director Designate
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Circassia Pharmaceuticals plc
b.	LEI	2138006YAT138TOGA556
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary Shares of 0.08p each GB00BJVD3B28
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	Price(s) Volume(s) 21.0p 477,340
d.	Aggregated information ·      Aggregated volume ·      Price	n/a
e.	Date of the transaction	05/12/2019
f.	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

DSHBDBDDXDGBGCL